文献速递产科母胎医学

体外受精/卵胞浆内单精子注射妊娠中颈项透明层测量、游离β-hCG与PAPP-A浓度的系统综述与Meta分析

Nuchal translucency measurement, free β-hCG and PAPP-A concentrations in IVF/ICSI pregnancies: systematic review and meta-analysis.
PubMed 文献 · Prenat Diagn · 2017-05-29

该系统综述与Meta分析评估辅助生殖技术(尤其是体外受精与卵胞浆内单精子注射新鲜胚胎移植)对孕早期唐氏综合征联合筛查指标的影响。结果显示卵胞浆内单精子注射组游离β-hCG略高于自然妊娠对照组,体外受精/卵胞浆内单精子注射各组PAPP-A均低于对照组,颈项透明层测量无统计学差异。

要点

  • 卵胞浆内单精子注射组游离β-hCG中位MoM比值略高于对照组(RR=1.09,95%CI:1.03-1.16)。
  • 体外受精/卵胞浆内单精子注射、体外受精、卵胞浆内单精子注射组PAPP-A均低于对照组。
  • 体外受精与卵胞浆内单精子注射组颈项透明层测量与对照组均无统计学差异。

核心结论

  • 辅助生殖技术妊娠中游离β-hCG与PAPP-A浓度存在差异,可能源于辅助生殖技术妊娠胎盘形成过程的改变。
  • 进一步区分辅助生殖技术妊娠亚组可能有助于解释辅助生殖技术与自然妊娠之间生物标志物浓度、产前行为及产科结局的差异。

研究设计与样本

  • 系统文献检索,纳入评估辅助生殖技术(尤其是体外受精与卵胞浆内单精子注射新鲜胚胎移植)对颈项透明层、游离β-hCG与PAPP-A测量影响的研究。
  • 对辅助生殖技术与自然妊娠(对照组)中位数倍数中位值(m0 MoM)的比值进行Meta分析与描述性图形展示。

主要发现

  • 卵胞浆内单精子注射组游离β-hCG略高于对照组(RR=1.09,95%CI:1.03-1.16),体外受精组与对照组无统计学差异(RR=1.03,95%CI:0.94-1.12)。
  • 体外受精/卵胞浆内单精子注射组PAPP-A低于对照组(RR=0.85,95%CI:0.80-0.90)。
  • 体外受精组PAPP-A低于对照组(RR=0.82,95%CI:0.74-0.89)。
  • 卵胞浆内单精子注射组PAPP-A低于对照组(RR=0.83,95%CI:0.79-0.86)。
  • 颈项透明层测量在体外受精组(RR=1.00,95%CI:0.94-1.08)与卵胞浆内单精子注射组(RR=1.01,95%CI:0.97-1.05)与对照组均无统计学差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

So far, data on the effect of assisted reproductive technologies (ART) on the components of first trimester combined screening for Down syndrome are still controversial. A systematic search of the literature was performed in order to identify the effect of ART, particularly in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) with fresh embryo transfer, on the nuchal translucency, free beta-human chorionic gonadotrophin and pregnancy-associated plasma protein-A measurements. Moreover, a meta-analysis and a descriptive graphical representation of the ratios between ART and spontaneous pregnancies (controls) values of median of the multiple of median (m0 MoM) were performed. Free beta-human chorionic gonadotrophin test showed slightly higher values in the ICSI group than controls (RR = 1.09, 95%CI: 1.03-1.16) but not in the IVF group (RR = 1.03, 95%CI: 0.94-1.12). Pregnancy-associated plasma protein-A values for IVF/ICSI, IVF and ICSI showed lower values in comparison with controls (RR, 95%CI 0.85, 0.80-0.90; 0.82, 0.74-0.89 and 0.83, 0.79-0.86, respectively). The nuchal translucency measurement did not show any statistical differences between study groups (IVF and ICSI) and controls (RR = 1.00, 95%CI: 0.94-1.08 and RR = 1.01, 95%CI: 0.97-1.05, respectively). These results may be due to alterations in the placentation of ART pregnancies. Differentiating further subgroups of ART pregnancies may explain the differences in biomarker concentrations, in prenatal behavior and in obstetric outcomes between ART and spontaneous pregnancies. © 2017 John Wiley & Sons, Ltd.

来源:Prenat Diagn,查看原文。版权归原作者所有。

引用

  1. Cavoretto P, Giorgione V, Cipriani S, et al. Nuchal translucency measurement, free β-hCG and PAPP-A concentrations in IVF/ICSI pregnancies: systematic review and meta-analysis. Prenat Diagn. 2017. PMID: 28419502. doi:10.1002/pd.5052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。